Skip to main content

森萱医药 — Investor Relations & Filings

Ticker · 920946 Beijing Stock Exchange Manufacturing
Filings indexed 417 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920946

About 森萱医药

Jiangsu Senxuan Pharmaceutical Co., Ltd. specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company’s product portfolio includes key intermediates for antiviral medications, such as those used in the treatment of HIV, and anticonvulsant agents like Primidone. Additionally, it produces high-purity chemical solvents including 1,4-dioxane and 1,3-dioxolane for diverse industrial applications. Senxuan Pharmaceutical maintains a focus on advanced chemical synthesis and large-scale manufacturing capabilities, adhering to international quality standards to support the global life sciences and chemical sectors. Its operations are characterized by a commitment to technical innovation and the supply of critical chemical building blocks for complex therapeutic formulations.

Recent filings

Filing Released Lang Actions
2025年年度报告业绩说明会预告公告
Regulatory Filings
2026-05-06 Chinese
关于召开2025年年度股东会通知公告(提供网络投票)
Regulatory Filings
2026-04-21 Chinese
第四届董事会第十三次会议决议公告
Regulatory Filings
2026-04-21 Chinese
2025年度内部控制自我评价报告
Regulatory Filings
2026-04-21 Chinese
2025年度董事会工作报告
Regulatory Filings
2026-04-21 Chinese
关于向商业银行申请授信并贷款的公告
Regulatory Filings
2026-04-21 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.